Rapid use of real-world data in safety signal assessment

被引：0
|
作者：
McDermott, Rachel [1 ]
Patadia, Vaishali [2 ]
von Klot, Stephanie [3 ]
Asubonteng, Julius [4 ]
Miller, Mary K. [5 ]
Golchin, Negar [6 ]
Manlik, Katrin [7 ]
机构：
[1] Shionogi BV, Amsterdam, Netherlands
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[4] Regeneron Pharmaceut, Tarrytown, NY USA
[5] Genentech Roche, San Francisco, CA USA
[6] Bristol Myers Squibb BMS, New York, NY USA
[7] Bayer AG, Leverkusen, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1056
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [1] A Framework for Rapid Analysis of Real-World Data in Safety Signal Assessment
    Manlik, Katrin
    Gipson, Geoffrey
    Golchin, Negar
    Salinas, Claudia A.
    von Klot, Stephanie
    Wang, Lu
    Asubonteng, Julius
    Miller, Mary K.
    Rivankar, Nayanika
    Vendetti, Neika
    Patadia, Vaishali
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 598 - 599
  • [2] Adopting a Framework for Rapid Real-World Data Analyses in Safety Signal Assessment
    Wang, Lu
    Golchin, Negar
    von Klot, Stephanie
    Salinas, Claudia A.
    Manlik, Katrin
    Patadia, Vaishali
    Miller, Mary K.
    Asubonteng, Julius
    McDermott, Rachel
    Barberio, Julie
    Gipson, Geoffrey
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1014 - 1022
  • [3] Leveraging Real-World Data in Safety Signal Assessment
    Patadia, Vaishali
    Manlik, Katrin
    Gipson, Geoffrey
    Willis, Jenna C.
    Namuyinga, Ruth
    Mcdermott, Rachel
    Shaw, Anita
    Miller, Mary K.
    Asubonteng, Julius
    Golchin, Negar
    von Klot, Stephanie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1062 - 1070
  • [4] The use of real-world data to address questions of patient safety
    Yates, Mark
    Bechman, Katie
    Galloway, James
    RHEUMATOLOGY, 2020, 59 (01) : 26 - 30
  • [5] Use of Routinely Collected "Real-world" Data for the Postlicensure Safety Assessment of Vaccination During Pregnancy
    Regan, Annette K.
    Rowe, Stacey L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2025, 44 (02) : S108 - S110
  • [6] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [7] Real-world safety and tolerability data for lenvatinib use in unresectable hepatocellular cancer
    Celermajer, Y.
    Prince, D.
    Stratton, E.
    Davidson, S.
    Majumdar, A.
    Mccaughan, G.
    Levy, M.
    Strasser, S.
    Liu, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 42 - 43
  • [8] The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies
    Lamberti, Mary Jo
    Kubick, Wayne
    Awatin, Josephine
    McCormick, John
    Carroll, James
    Getz, Ken
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (06) : 778 - 783
  • [9] The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies
    Mary Jo Lamberti
    Wayne Kubick
    Josephine Awatin
    John McCormick
    James Carroll
    Ken Getz
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 778 - 783
  • [10] REAL-WORLD SAFETY AND TOLERABILITY DATA FOR LENVATINIB USE IN UNRESECTABLE HEPATOCELLULAR CANCER
    Celermajer, Yael
    Prince, David S.
    Stratton, Elisabeth
    Davidson, Scott
    Majumdar, Avik
    McCaughan, Geoffrey W.
    Levy, Miriam T.
    Strasser, Simone I.
    Liu, Ken
    HEPATOLOGY, 2020, 72 : 704A - 704A
12345